Salehi has also teamed up with UNMC pharmaceutical scientist and professor, Aaron Mohs, to address the issue of suboptimal illumination during tumour surgery, particularly medulloblastoma.
It includes brain stem glioma, craniopharyngioma, medulloblastoma and meningioma. Epigenetic therapy triggers myriad transposable elements to generate new antigens that could prime tumor cells for ...